CLINICAL_TRIALS
trial_result
· 2019-08-08
Clinical Trial Update: Real World Data on Gi(l)Otrif® Dose Adjustment
Summary
Real-world data study on dose adjustment for Gi(l)Otrif® in non-small cell lung carcinoma completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED | Results posted: 2019-08-08